1. Home
  2. Member Magazine
  3. The Cost of the Rare Fraud in the Biomedical and Diagnostics Industry

The Cost of the Rare Fraud in the Biomedical and Diagnostics Industry

April 1, 2021

Cover image of the Spring 2021 issue of Microcosm Magazine, showing a lab technologist at a microscope.
From the Spring 2021 issue of "Microcosm." In vitro diagnostics (IVDs) are an integral part of our health care system. Medical providers

Author: Amy Kullas, Ph.D.

Amy Kullas, Ph.D.
Amy Kullas, Ph.D., is the American Society for Microbiology's Director, Ethics.

Register for ASM Conference on Next-Generation Sequencing

Register Now

Discover ASM membership

Join or Renew

Get published in an ASM journal

Submit now

To Read the Full Story

Log In Create Account